We are live on ! Find out more
DMAC icon

DiaMedica Therapeutics
DMAC

45 hedge funds and large institutions have $36.5M invested in DiaMedica Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,300% more call options, than puts

Call options by funds: $264K | Put options by funds: $6K

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

57% more capital invested

Capital invested by funds: $23.3M → $36.5M (+$13.2M)

13% more funds holding

Funds holding: 40 → 45 (+5)

2.68% more ownership

Funds ownership: 13.05% → 15.74% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
45
Holders Change
+5
Holders Change %
+12.5%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
16
Reduced
5
Closed
5
Calls
$264K
Puts
$6K
Net Calls
+$258K
Net Calls Change
+$65K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.29M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$911K
3
CLG
Cooperman Leon G
+$534K
4
6CM
683 Capital Management
New York
+$359K
5
Goldman Sachs
Goldman Sachs
New York
+$325K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$107K
2
UBS Group
UBS Group
Switzerland
-$51.7K
3
PAS
Point72 Asia (Singapore)
Singapore
-$39.8K
4
Simplex Trading
Simplex Trading
Illinois
-$17.3K
5
CSS
Cubist Systematic Strategies
Connecticut
-$13.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
WIA
26
World Investment Advisors
California
$119K +$103K +21,915 New
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$105K +$11.2K +2,380 +14%
SCA
28
Stonebridge Capital Advisors
Minnesota
$95K – – –
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$91.2K +$1.42K +300 +2%
Citadel Advisors
30
Citadel Advisors
Florida
$87.5K +$20.2K +4,282 +36%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$84.5K +$73.4K +15,560 New
Raymond James Financial
32
Raymond James Financial
Florida
$82.9K +$72K +15,267 New
YIH
33
Y-Intercept (HK)
Hong Kong
$81.3K +$70.6K +14,973 New
Balyasny Asset Management
34
Balyasny Asset Management
Illinois
$79.2K +$68.8K +14,581 New
Charles Schwab
35
Charles Schwab
California
$72K – – –
MCA
36
Magnolia Capital Advisors
Mississippi
$55.2K +$755 +160 +2%
MPWT
37
MassMutual Private Wealth & Trust
Connecticut
$26.2K – – –
US Bancorp
38
US Bancorp
Minnesota
$23.5K – – –
UBS Group
39
UBS Group
Switzerland
$9.61K -$51.7K -10,970 -86%
TWC
40
TD Waterhouse Canada
Ontario, Canada
$5.8K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$5.73K – – –
LFA
42
Legend Financial Advisors
Pennsylvania
$5.43K – – –
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$2K -$2.24K -475 -59%
Bank of America
44
Bank of America
North Carolina
$1.14K -$19 -4 -2%
CPG
45
Cornerstone Planning Group
New Jersey
$485 – – –
PAS
46
Point72 Asia (Singapore)
Singapore
– -$39.8K -9,498 Closed
Simplex Trading
47
Simplex Trading
Illinois
– -$17.3K -3,662 Closed
CSS
48
Cubist Systematic Strategies
Connecticut
– -$13.7K -3,263 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$4.68K -1,118 Closed
JP Morgan Chase
50
JP Morgan Chase
New York
– -$113 -27 Closed
1
2

DMAC Hedge Fund Activity: Q4 2024 in Review

45 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in DiaMedica Therapeutics (DMAC) for Q4 2024, worth a combined $36.5M — up 57% from $23.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new DMAC positions and 5 closed out — a net gain of 7 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.29M. The largest seller was Morgan Stanley, cutting an estimated $107K.

  • 45 institutional investors held DiaMedica Therapeutics (DMAC) as of Q4 2024, up from 40 in Q3 2024.
  • Funds reported $36.5M of DiaMedica Therapeutics stock for Q4 2024, up 57% quarter-over-quarter.
  • 12 funds opened new DiaMedica Therapeutics positions in Q4 2024 and 5 closed out, a net change of +7 holders.
  • The largest DiaMedica Therapeutics buyer in Q4 2024 was Susquehanna International Group, an estimated $1.29M added.
  • The largest DiaMedica Therapeutics seller in Q4 2024 was Morgan Stanley, an estimated $107K sold.

Based on aggregated 13F filings for Q4 2024.